ArticleCancers2020

Silencing of VEGFR2 by RGD-Modified Lipid Nanoparticles Enhanced the Efficacy of Anti-PD-1 Antibody by Accelerating Vascular Normalization and Infiltration of T Cells in Tumors.

Riki Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.